Effect of sunitinib in a patient with primary imatinib-resistant gastrointestinal stromal tumor.

被引：0
|
作者：
Xue, Zhigang
Ma, Zhiqiang
Kang, Weiming
Yu, Jianchun
机构：
[1] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing, Peoples R China
[2] Peking Union Med Coll Hosp, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e23516
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e23516
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Molecular analysis of secondary kinase mutations in imatinib-resistant gastrointestinal stromal tumors
    Ken-Hong Lim
    Ming-Jer Huang
    Li-Tzong Chen
    Tsang-En Wang
    Chien-Liang Liu
    Cheng-Shyong Chang
    Mei-Chin Liu
    Reuy-Kuen Hsieh
    Chin-Yuan Tzen
    Medical Oncology, 2008, 25 : 207 - 213
  • [42] Long-term survival INA phase III trial of sunitinib in imatinib-resistant/intolerant gastrointestinal stromal tumor with novel statistical analysis to account for crossover
    Garrett, C.
    Huang, X.
    Casali, P.
    Schoffski, P.
    Blackstein, M.
    Shah, M.
    Verweij, J.
    Tassel, V
    Baum, C.
    Demetri, G.
    ANNALS OF ONCOLOGY, 2008, 19 : 12 - 12
  • [43] Dual Targeting of Insulin Receptor and KIT in Imatinib-Resistant Gastrointestinal Stromal Tumors
    Chen, Weicai
    Kuang, Ye
    Qiu, Hai-Bo
    Cao, Zhifa
    Tu, Yuqing
    Sheng, Qing
    Eilers, Grant
    He, Quan
    Li, Hai-Long
    Zhu, Meijun
    Wang, Yuexiang
    Zhang, Rongqing
    Wu, Yeqing
    Meng, Fanguo
    Fletcher, Jonathan A.
    Ou, Wen-Bin
    CANCER RESEARCH, 2017, 77 (18) : 5107 - 5117
  • [44] Molecular analysis of secondary kinase mutations in imatinib-resistant gastrointestinal stromal tumors
    Lim, Ken-Hong
    Huang, Ming-Jer
    Chen, Li-Tzong
    Wang, Tsang-En
    Liu, Chien-Liang
    Chang, Cheng-Shyong
    Liu, Mei-Chin
    Hsieh, Reuy-Kuen
    Tzen, Chin-Yuan
    MEDICAL ONCOLOGY, 2008, 25 (02) : 207 - 213
  • [45] Clinical significance of surgical treatment for imatinib-resistant gastrointestinal stromal tumors.
    Hashimoto, Tadayoshi
    Takahashi, Tsuyoshi
    Kurokawa, Yukinori
    Kato, Ryo
    Wada, Noriko
    Tanaka, Koji
    Miyazaki, Yasuhiro
    Makino, Tomoki
    Yamasaki, Makoto
    Nakajima, Kiyokazu
    Mori, Masaki
    Doki, Yuichiro
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [46] Massive Intra-Abdominal Imatinib-Resistant Gastrointestinal Stromal Tumor in a 21-Year-Old Male
    Falor, Ann
    Arrington, Amanda K.
    Luu, Carrie
    Schoellhammer, Hans F.
    Ko, Michelle
    Chow, Warren
    D'Apuzzo, Massimo
    Park, Jinha
    Kim, Joseph
    CASE REPORTS IN MEDICINE, 2013, 2013
  • [47] Successful treatment with sunitinib in a young patient with metastatic gastrointestinal stromal tumor after failure on adjuvant imatinib
    Kapoor, Rakesh
    Khosla, Divya
    Kumar, Pankaj
    Kumar, Narendra
    Bera, Anjan
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2011, 7 (04) : 491 - U3
  • [48] Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib
    Montemurro, M.
    Schoffski, P.
    Reichardt, P.
    Gelderblom, H.
    Schuette, J.
    Hartmann, J. T.
    von Moos, R.
    Seddon, B.
    Joensuu, H.
    Wendtner, C. M.
    Weber, E.
    Gruenwald, V.
    Roth, A.
    Leyvraz, S.
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (13) : 2293 - 2297
  • [49] Detecting Secondary C-KIT Mutations in the Peripheral Blood of Patients with Imatinib-Resistant Gastrointestinal Stromal Tumor
    Wada, Noriko
    Kurokawa, Yukinori
    Takahashi, Tsuyoshi
    Hamakawa, Takuya
    Hirota, Seiichi
    Naka, Tetsuji
    Miyazaki, Yasuhiro
    Makino, Tomoki
    Yamasaki, Makoto
    Nakajima, Kiyokazu
    Takiguchi, Shuji
    Mori, Masaki
    Doki, Yuichiro
    ONCOLOGY, 2016, 90 (02) : 112 - 117
  • [50] Treatment of gastrointestinal stromal tumours: imatinib, sunitinib - and then?
    Nilsson, Bengt
    Nilsson, Ola
    Ahlman, Hakan
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (04) : 457 - 468
12345